RODRIGUEZ RAUL R — SEC insider filings
SEC reporting owner CIK 1190279. 25 insider filings on record with FilingPulse; latest filed 2026-09-03.
Transaction summary — filings shown
Covers all 25 filings on record, filed 2021-01-29 to 2026-09-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 1,000,000 shares, $688,400 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 5 legs across 3 filings — 82,586 shares, $295,753 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 39.
- Largest priced transaction: purchase of 1,000,000 shares @ $0.69 ($688,400) in RIGEL PHARMACEUTICALS INC, filed 2022-06-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| RIGEL PHARMACEUTICALS INC (RIGL) | CEO, President, Director | 25 | 1 leg · 1,000,000 sh · $688,400 | 5 legs · 82,586 sh · $295,753 | 39 |
Insider filings — RODRIGUEZ RAUL R
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-03 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Tax withholding (F): 2,424 @ $47.50 | EDGAR |
| 2026-06-22 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/award (A): 31,700 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Tax withholding (F): 2,424 @ $29.86 | EDGAR |
| 2026-02-19 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/award (A): 53,915 @ $0 | EDGAR |
| 2026-02-12 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Tax withholding (F): 7,607 @ $34.62 | EDGAR |
| 2026-02-04 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Option exercise (M): 40,000 @ $27.40 · Tax withholding (F): 35,211 @ $37 · Option exercise (M): 40,000 @ $27.40 · Tax withholding (F): 35,424 @ $37 · Tax withholding (F): 14,110 @ $36.01 · Option exercise (M): 40,000 (derivative) @ $0 · +1 more | EDGAR |
| 2025-09-17 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/award (A): 31,700 (derivative) @ $0 | EDGAR |
| 2025-03-19 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/award (A): 26,250 (derivative) @ $0 · Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-02-06 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Sale (S): 4,952 @ $20.92 · Sale (S): 4,400 @ $21.93 | EDGAR |
| 2025-01-31 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/award (A): 42,300 @ $0 · Grant/award (A): 63,400 (derivative) @ $0 | EDGAR |
| 2025-01-28 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Option exercise (M): 45,000 @ $21.40 · Tax withholding (F): 44,078 @ $22.17 · Option exercise (M): 45,000 @ $21.40 · Tax withholding (F): 44,078 @ $22.17 · Option exercise (M): 45,000 (derivative) @ $0 · Option exercise (M): 45,000 (derivative) @ $0 | EDGAR |
| 2024-11-26 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-09-04 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/award (A): 32,500 (derivative) @ $0 | EDGAR |
| 2024-03-01 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/award (A): 300,000 (derivative) @ $0 · Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2024-02-06 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Sale (S): 22,349 @ $1.13 · Sale (S): 30,545 @ $1.14 | EDGAR |
| 2024-01-25 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/award (A): 400,000 @ $0 · Grant/award (A): 600,000 (derivative) @ $0 | EDGAR |
| 2023-02-07 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/award (A): 300,000 @ $0 · Sale (S): 20,340 @ $1.75 · Grant/award (A): 600,000 (derivative) @ $0 | EDGAR |
| 2023-01-30 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2022-12-30 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2022-09-16 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2022-06-13 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Purchase (P): 1,000,000 @ $0.69 | EDGAR |
| 2022-01-26 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/award (A): 200,000 @ $0 · Grant/award (A): 400,000 (derivative) @ $0 | EDGAR |
| 2021-11-05 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2021-04-02 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/award (A): 162,500 (derivative) @ $0 | EDGAR |
| 2021-01-29 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/award (A): 525,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-01-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1190279 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs